featured
Safety and Efficacy of Prophylactic Levetiracetam for the Prevention of Epileptic Seizures in the Acute Phase of Intracerebral Haemorrhage
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and efficacy of prophylactic levetiracetam for prevention of epileptic seizures in the acute phase of intracerebral haemorrhage (PEACH): a randomised, double-blind, placebo-controlled, phase 3 trial
Lancet Neurol 2022 Sep 01;21(9)781-791, L Peter-Derex, F Philippeau, P Garnier, N André-Obadia, S Boulogne, H Catenoix, P Convers, L Mazzola, M Gouttard, M Esteban, J Fontaine, L Mechtouff, E Ong, TH Cho, N Nighoghossian, N Perreton, A Termoz, J Haesebaert, AM Schott, M Rabilloud, C Pivot, C Dhelens, A Filip, Y Berthezène, S Rheims, F Boutitie, L DerexFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.